# Rubai

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rubai

- Industry: Biotechnology
- Headquarters: Liaocheng, China
- Website: www.reprobiotech.com
- Latest round: Series A (Jul 1, 2021)
- Investors on record: 3

## About

Established in 2016 and based in China, Rubai is medical instrument supplier that focus on reproductive medicine technology. The core team come from the field of reproductive clinical medicine, reproductive genetics and embryonic stem cells. In July 2021, the company raised series A funding from new investor.

The company main business is research and development of assisted reproduction reagents and consumables. The company main product has medium with HEPES, vitrification straw and channel fertilized culture dish and so on.

## Funding rounds

- Series A, Jul 1, 2021 — Shanghai Creation Investment, Solid Wood Investment, Dianshi Fund

## Investors

- Shanghai Creation Investment (https://capitalatlas.ai/funds/shanghai-creation-investment) — Series A
- Solid Wood Investment (https://capitalatlas.ai/funds/solid-wood-investment) — Series A
- Dianshi Fund (https://capitalatlas.ai/funds/dianshi-fund) — Series A